SCHEMBL30028448

SCHEMBL30028448

NNc1ccnc2cc(Cl)ccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.68
▸ FERMT2 Q96AC1 4/20 0.65
▸ MAPT P10636 4/20 0.64
▸ TDP1 Q9NUW8 3/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ CCR1 P32246 1/20 0.64
▸ NR4A2 P43354 2/20 0.62
▸ GAA P10253 2/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ SOS2 Q07890 1/20 0.61
▸ MEN1 O00255 1/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ KMT5B Q4FZB7 1/20 0.59
▸ KMT5C Q86Y97 1/20 0.59
▸ ATM Q13315 1/20 0.59
▸ PKM P14618 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455864 1.00 CYP1A2 (0.68) CYP1A2FERMT2MAPTTDP1KMT2A
Hydrochloric Acid SCHEMBL5680197 0.98 CYP1A2 (0.66) CYP1A2FERMT2MAPTTDP1KMT2A
SCHEMBL2477414 0.86 NR4A2 (0.61) CYP1A2FERMT2MAPTTDP1KMT2A
SCHEMBL23904649 0.82 CYP1A2 (0.68) CYP1A2FERMT2MAPTTDP1KMT2A
SCHEMBL12840976 0.82 CYP1A2 (0.68) CYP1A2FERMT2MAPTTDP1KMT2A
SCHEMBL12223738 0.81 FERMT2 (0.78) CYP1A2FERMT2MAPTTDP1KMT2A
SCHEMBL8738060 0.81 CYP1A2 (1.00) CYP1A2FERMT2KMT2ACCR1NR4A2
SCHEMBL729361 0.81 MAPT (0.71) CYP1A2FERMT2MAPTTDP1KMT2A
SCHEMBL1147519 0.79 FERMT2 (1.00) CYP1A2FERMT2KMT2ACCR1NR4A2
SCHEMBL3398399 0.79 NR4A2 (0.76) CYP1A2FERMT2MAPTTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230109016-A1 IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME IMMUNDIAGNOSTIK AG (DE) 2023-04-06 — — US claimed
EP-4103946-A1 IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME Immundiagnostik AG (DE) 2022-12-21 — — EP claimed
EP-4398902-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF AMYLOID PEPTIDE INTERACTIONS WITH GLYCOSAMINOGLYCANS, METHODS OF TREATMENT, AND USE THEREOF Gismo Therapeutics, Inc. (US) 2024-07-17 — — EP disclosed
WO-2023038876-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF AMYLOID PEPTIDE INTERACTIONS WITH GLYCOSAMINOGLYCANS, METHODS OF TREATMENT, AND USE THEREOF GISMO THERAPEUTICS, INC. (US) 2023-03-16 — — WO disclosed
Send feedback